Febe van Maldegem
- Molecular Biology
- Immunology top 10%
- Oncology top 10%
- Pathology and Forensic Medicine top 10%
- Cancer Research
- Co-authors
- Richard J. BendeCarel J.M. van NoeselJan AtenMirza M. IduAllard C. van der WalThera A.M. WormhoudtOnno J. de BoerPeter Teeling
- Topics
- Cancer Immunotherapy and Biomarkers (5 papers)Monoclonal and Polyclonal Antibodies Research (4 papers)Lymphoma Diagnosis and Treatment (4 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
Febe van Maldegem
20 papers receiving 846 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 312
- Immunology 307
- Oncology 235
- Pathology and Forensic Medicine 201
- Cancer Research 114
Countries citing papers authored by Febe van Maldegem
This map shows the geographic impact of Febe van Maldegem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Febe van Maldegem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Febe van Maldegem more than expected).
Fields of papers citing papers by Febe van Maldegem
This network shows the impact of papers produced by Febe van Maldegem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Febe van Maldegem. The network helps show where Febe van Maldegem may publish in the future.
Co-authorship network of co-authors of Febe van Maldegem
This figure shows the co-authorship network connecting the top 25 collaborators of Febe van Maldegem. A scholar is included among the top collaborators of Febe van Maldegem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Febe van Maldegem. Febe van Maldegem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 2 | |
| 3 | 73 | |
| 4 | 1 | |
| 5 | 41 | |
| 6 | 1 | |
| 7 | 146 | |
| 8 | 1 | |
| 9 | 13 | |
| 10 | 4 | |
| 11 | 11 | |
| 12 | 24 | |
| 13 | 9 | |
| 14 | 61 | |
| 15 | 166 | |
| 16 | 58 | |
| 17 | 76 | |
| 18 | 54 | |
| 19 | Antigen receptors and somatic hypermutation in B-cell chronic lymphocytic leukemia with Richter's transformation. | 17 |
| 20 | 95 |
About Febe van Maldegem
Febe van Maldegem is a scholar working on Biophysics, Immunology and Allergy and Immunology, having authored 20 papers that have together received 858 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers) and Lymphoma Diagnosis and Treatment (4 papers). The work is most often cited by research in Immunology (307 citations), Pathology and Forensic Medicine (201 citations) and Dermatology (93 citations). Febe van Maldegem has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Richard J. Bende, Carel J.M. van Noesel, Jan Aten, Mirza M. Idu, Allard C. van der Wal, Thera A.M. Wormhoudt, Onno J. de Boer, Peter Teeling, J. J. van der Meer and Chris M. van der Loos. Their work appears in journals such as Nucleic Acids Research, Nature Communications and The Journal of Experimental Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.